Shares of Novavax Inc. /zigman2/quotes/202614340/composite NVAX -2.88% slid 6.12% to $79.47 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP -0.52% rising 0.63% to 13,855.13 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.45% rising 0.29% to 34,364.50. This was the stock's ninth consecutive day of losses. Novavax Inc. closed $252.21 short of its 52-week high ($331.68), which the company reached on February 9th.
The stock underperformed when compared to some of its competitors Monday, as Replimune Group Inc. /zigman2/quotes/203971249/composite REPL +2.15% rose 2.12% to $21.20, VBI Vaccines Inc. /zigman2/quotes/201705917/composite VBIV -2.10% remained unchanged, and AnaptysBio Inc. /zigman2/quotes/205822596/composite ANAB +0.72% rose 4.81% to $32.48. Trading volume (12.9 M) eclipsed its 50-day average volume of 5.9 M.